| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/21/2010 | US20100015217 Enhancing Pulmonary Host Defense via Administration of Granulocyte-Macrophage Colony Stimulating Factor |
| 01/21/2010 | US20100015205 Biocompatible amino acid anhydride polymers |
| 01/21/2010 | US20100015200 Drug Delivery Medical Device |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015171 Vaccines comprising tb 10.4 |
| 01/21/2010 | US20100015167 in vitro method of screening an individual for metastatic colorectal cancer cells or primary and/or metastatic stomach or esophageal cancer cells; vaccine comprising a protein that comprises human sucrase isomaltase protein |
| 01/21/2010 | US20100015166 Therapeutic antibodies |
| 01/21/2010 | US20100015163 Dendritic cell potentiation |
| 01/21/2010 | US20100015153 Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells and Antibodies That Identify the Same |
| 01/21/2010 | US20100015152 Diagnostic and therapeutic methods |
| 01/21/2010 | US20100015151 Polypeptides from neisseria meningitidis |
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015147 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside |
| 01/21/2010 | US20100015144 Methods for dosing an activin-actriia antagonist and monitoring of treated patients |
| 01/21/2010 | US20100015143 Compositions and Methods Relating to Modulation of Immune System Components |
| 01/21/2010 | US20100015138 Crystal structure of Staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/21/2010 | US20100015136 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 01/21/2010 | US20100015132 Uses of mammalian cytokines and agonists; related reagents |
| 01/21/2010 | US20100015130 Disc-1 pathway activators in the control of neurogenesis |
| 01/21/2010 | US20100015126 Methods of Binding of Cross-Beta Structures By Chaperones |
| 01/21/2010 | US20100015125 Methods and compositions for enhancing immune memory by blocking intrahepatic activated t cell deletion |
| 01/21/2010 | US20100015123 Novel thrombolytic molecules and a process therefor |
| 01/21/2010 | US20100015122 Cloning of honey bee allergen |
| 01/21/2010 | US20100015121 Inhibiting gs-fdh to modulate no bioactivity |
| 01/21/2010 | US20100015120 Hybrid protein that converts arachidonic acid into prostacyclin |
| 01/21/2010 | US20100015119 Epithelium-improving agent |
| 01/21/2010 | US20100015117 Compositions and methods for targeting a polypeptide to the central nervous system |
| 01/21/2010 | US20100015116 Designer Ubiquitin Ligases For Regulation Of Intracellular Pathogenic Proteins |
| 01/21/2010 | US20100015115 Compound preparation for quickly reducing oxidative stress and preparation of the same |
| 01/21/2010 | US20100015101 Novel tumor antigen peptides |
| 01/21/2010 | US20100015099 Materials and methods relating to treatment of injury and disease to the central nervous system |
| 01/21/2010 | US20100015094 Antiviral nucleoside analogs |
| 01/21/2010 | US20100015093 Methods and compositions of treating a flaviviridae family viral infection |
| 01/21/2010 | US20100015092 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/21/2010 | US20100015091 Modified stat1 transgene that confers interferon hyperresponsiveness, methods and uses therefor |
| 01/21/2010 | US20100015090 Administering a Hepatitis C virus NS3/4A protease inhibitor such as telaprevir and a cytochrome P450 monooxygenase inhibitor such as ritonavir |
| 01/21/2010 | US20100015089 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 01/21/2010 | US20100015088 Compounds and compositions for delivering active agents |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015086 Use of il-22 for the treatment of conditions of metabolic disorders |
| 01/21/2010 | US20100015085 Phase 2 inducers and related signaling pathways protect cartilage against inflammation/infection, apoptosis and stress |
| 01/21/2010 | US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them |
| 01/21/2010 | US20100015056 Uranium-chelating peptides and uses thereof |
| 01/21/2010 | US20100015050 Peg and targeting ligands on nanoparticle surface |
| 01/21/2010 | US20100015048 Internalizing Anti-CD74 Antibodies and Methods of Use |
| 01/21/2010 | US20100015046 Camptothecin-Binding Moiety Conjugates |
| 01/21/2010 | DE102008032361A1 Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie The use of factor VIII and vWF and vWF-containing concentrates for the treatment of induced platelet inhibitors coagulopathy |
| 01/21/2010 | DE102006052560B4 Anti-diabetogene Calcium-Peptid-Zusammensetzung Anti-diabetogenic calcium peptide composition |
| 01/21/2010 | DE10004815B4 Menschliche intestinale Natriumphosphat-Kotransporter Human intestinal sodium phosphate cotransporter |
| 01/21/2010 | CA2849218A1 Compositions and methods for treating disorders associated with overweight animals |
| 01/21/2010 | CA2750727A1 Treatment of inflammatory bowel diseases with mammal beta defensins |
| 01/21/2010 | CA2736311A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | CA2731296A1 New mutated netrin 4 proteins, fragments thereof and their uses as drugs |
| 01/21/2010 | CA2731218A1 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome |
| 01/21/2010 | CA2730996A1 Long-acting interferons and derivatives thereof and methods thereof |
| 01/21/2010 | CA2730933A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | CA2730923A1 Compositions comprising mg29 nucleic acids, polypeptides and associated methods of use |
| 01/21/2010 | CA2730847A1 Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 01/21/2010 | CA2730826A1 Antibacterial combination therapy for the treatment of gram positive bacterial infections |
| 01/21/2010 | CA2730789A1 Treatment of inflammatory bowel diseases with mammal beta defensins |
| 01/21/2010 | CA2730686A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730666A1 Treatment of rheumatoid arthritis with mammal beta defensins |
| 01/21/2010 | CA2730663A1 Anticancer compounds |
| 01/21/2010 | CA2730615A1 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 01/21/2010 | CA2730531A1 Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
| 01/21/2010 | CA2730369A1 Compositions and methods for modulating nod-like receptor activity and uses thereof |
| 01/21/2010 | CA2729188A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles |
| 01/20/2010 | EP2145962A2 Process for the manufacture of eptifibatide |
| 01/20/2010 | EP2145961A2 Porcine adenovirus type 3 genome |
| 01/20/2010 | EP2145958A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/20/2010 | EP2145957A1 Compositions for enhancing delivery of double-stranded RNA to regulate gene expression in mammalian cells |
| 01/20/2010 | EP2145898A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/20/2010 | EP2145897A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/20/2010 | EP2145896A2 Recovery of a heat shock protein |
| 01/20/2010 | EP2145630A2 Angiotensin-converting enzyme inhibitory peptides |
| 01/20/2010 | EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/20/2010 | EP2145623A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages |
| 01/20/2010 | EP2144927A1 Anti-tumor drug, medicament, composition, and use thereof |
| 01/20/2010 | EP2144672A1 A method for treating inflammation and controlled-release material capable of providing same |
| 01/20/2010 | EP2144625A1 A controlled release enzymatic composition and methods of use |
| 01/20/2010 | EP2144624A1 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof |
| 01/20/2010 | EP2144615A2 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 01/20/2010 | EP2144613A2 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 01/20/2010 | EP2144606A2 Remedy for the treatment of cardio-vascular diseases or disorders |
| 01/20/2010 | EP1809653B1 Substituted nonadepsipeptides |
| 01/20/2010 | EP1774332B1 Immune response assessment method |
| 01/20/2010 | EP1686964B1 Microparticles comprising somatostatin analogues |
| 01/20/2010 | EP1678204B1 Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | EP1594529B1 Analogues of glp-1 |
| 01/20/2010 | EP1507797B1 Inhibitors of proteins from the rho-gef family |
| 01/20/2010 | EP1351841B1 Oil maintenance indicator |
| 01/20/2010 | EP1218027B1 Composition for stabilizing corneal tissue during or after orthokeratological lens wear |
| 01/20/2010 | EP1204870B1 Method for determining physiological effects of hemoglobin |
| 01/20/2010 | EP1188830B1 Novel hemopoietin receptor protein ,nr10 |
| 01/20/2010 | EP1117419B1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | EP0971724B1 Expression of active human factor ix in mammary tissue of transgenic animals |